The NM_003494.4: c.797T>G variant in DYSF, which is also known as NM_001130987.2: c.893T>G p.(Leu298Arg), is a missense variant expected to cause the substitution of leucine at amino acid 266 with arginine, p.(Leu266Arg). This variant has been identified in one individual with progressive limb girdle muscle weakness and absent dysferlin in muscle and blood monocytes, in whom it was reported in unconfirmed phase with a pathogenic variant (NM_003494.4: c.1663C>T p.(Arg555Trp), 0.5 pts, Jain Foundation Dysferlin Registry internal data communication; PM3_Supporting, PP4_Strong). This variant is absent from gnomAD v.4.1.0, meeting the criteria for PM2_Supporting. Immunofluorescence and 2-A assays of dysferlin membrane localization in HEK293T cells showed the Leu266Arg protein did not reach the cell membrane, indicating an impact on protein function (PMID: 35028538) (PS3_Moderate). The computational predictor REVEL gives a score of 0.777, which is above the LGMD VCEP threshold of ≥0.70, evidence that correlates with impact to DYSF function (PP3). Another missense change at the same residue, NM_003494.4: c.797T>C p.(Leu266Pro), has been reported in association with dysferlinopathy (LOVD Individual #00215299, PMID: 18853459), but the clinical significance of this variant remains uncertain (PM5_Supporting not met). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (specifications v2.0.0; 04/30/2026): PM3_Supporting, PP4_Strong, PM2_Supporting, PS3_Moderate, PP3.